Literature DB >> 18174536

Risky business: medical discourse, breast cancer, and narrative.

Elizabeth M Davis1.   

Abstract

This study explores the construction of risk and patient identity in medical discourse directed toward women with breast cancer. Eleven documents produced by the National Cancer Institute on the topic of breast cancer are studied using narrative analysis. A distinct patient narrative presents all women as at risk for breast cancer and creates an idealized patient identity that serves a prescriptive function for women. The narrative constructs an early-cancer experience where the patient is treatable and cancer is cured or controlled. There are no significant changes in the narrative after time.

Entities:  

Mesh:

Year:  2008        PMID: 18174536     DOI: 10.1177/1049732307309002

Source DB:  PubMed          Journal:  Qual Health Res        ISSN: 1049-7323


  5 in total

1.  Exploring the experience of recurrence with advanced cancer for people who perceived themselves to be cancer free: a grounded theory study.

Authors:  Denice Economou; Catherine Walshe; Sarah G Brearley
Journal:  Support Care Cancer       Date:  2021-01-02       Impact factor: 3.603

2.  Life course changes provoked by chronic disease: A study on everyday life for patients with systemic lupus erythematosus.

Authors:  Zheng Huangfu
Journal:  Int J Nurs Sci       Date:  2020-05-29

3.  Breast cancer patients' experience of external-beam radiotherapy.

Authors:  Julie B Schnur; Suzanne C Ouellette; Dana H Bovbjerg; Guy H Montgomery
Journal:  Qual Health Res       Date:  2009-05

4.  "It's not easy to acknowledge that I'm ill": a qualitative investigation into the health seeking behavior of rural Palestinian women.

Authors:  Linda Majaj; Majed Nassar; Manuela De Allegri
Journal:  BMC Womens Health       Date:  2013-05-24       Impact factor: 2.809

Review 5.  Mapping the risk perception and communication gap between different professions of healthcare providers in cancer care: a cross-sectional protocol.

Authors:  Trine Stub; Frauke Musial; Sara A Quandt; Thomas A Arcury; Anita Salamonsen; Agnete Kristoffersen; Gro Berntsen
Journal:  BMJ Open       Date:  2015-09-03       Impact factor: 2.692

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.